University of Texas Southwestern Medical Center, Dallas (K.S., A.C., T.S., P.H.J., A.K., C.R.A., A.R.).
Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX (S.S.V.).
Circulation. 2020 Aug 18;142(7):657-669. doi: 10.1161/CIRCULATIONAHA.120.045713. Epub 2020 Jun 18.
High-density lipoprotein (HDL) cholesterol concentration (HDL-C) is an established atheroprotective marker, in particular for coronary artery disease; however, HDL particle concentration (HDL-P) may better predict risk. The associations of HDL-C and HDL-P with ischemic stroke and myocardial infarction (MI) among women and Blacks have not been well studied. We hypothesized that HDL-P would consistently be associated with MI and stroke among women and Blacks compared with HDL-C.
We analyzed individual-level participant data in a pooled cohort of 4 large population studies without baseline atherosclerotic cardiovascular disease: DHS (Dallas Heart Study; n=2535), ARIC (Atherosclerosis Risk in Communities; n=1595), MESA (Multi-Ethnic Study of Atherosclerosis; n=6632), and PREVEND (Prevention of Renal and Vascular Endstage Disease; n=5022). HDL markers were analyzed in adjusted Cox proportional hazard models for MI and ischemic stroke.
In the overall population (n=15 784), HDL-P was inversely associated with the combined outcome of MI and ischemic stroke, adjusted for cardiometabolic risk factors (hazard ratio [HR] for quartile 4 [Q4] versus quartile 1 [Q1], 0.64 [95% CI, 0.52-0.78]), as was HDL-C (HR for Q4 versus Q1, 0.76 [95% CI, 0.61-0.94]). Adjustment for HDL-C did not attenuate the inverse relationship between HDL-P and atherosclerotic cardiovascular disease, whereas adjustment for HDL-P attenuated all associations between HDL-C and events. HDL-P was inversely associated with the individual end points of MI and ischemic stroke in the overall population, including in women. HDL-P was inversely associated with MI among White participants but not among Black participants (HR for Q4 versus Q1 for Whites, 0.49 [95% CI, 0.35-0.69]; for Blacks, 1.22 [95% CI, 0.76-1.98]; =0.001). Similarly, HDL-C was inversely associated with MI among White participants (HR for Q4 versus Q1, 0.53 [95% CI, 0.36-0.78]) but had a weak direct association with MI among Black participants (HR for Q4 versus Q1, 1.75 [95% CI, 1.08-2.83]; <0.0001).
Compared with HDL-C, HDL-P was consistently associated with MI and ischemic stroke in the overall population. Differential associations of both HDL-C and HDL-P for MI by Black ethnicity suggest that atherosclerotic cardiovascular disease risk may differ by vascular domain and ethnicity. Future studies should examine individual outcomes separately.
高密度脂蛋白(HDL)胆固醇浓度(HDL-C)是一种已确立的抗动脉粥样硬化标志物,特别是对冠状动脉疾病;然而,HDL 颗粒浓度(HDL-P)可能更好地预测风险。HDL-C 和 HDL-P 与女性和黑人缺血性卒中和心肌梗死(MI)之间的关系尚未得到很好的研究。我们假设 HDL-P 与 MI 和卒中的相关性在女性和黑人中始终优于 HDL-C。
我们分析了来自 4 个大型人群研究的个体水平参与者数据,这些研究均无基线动脉粥样硬化性心血管疾病:DHS(达拉斯心脏研究;n=2535)、ARIC(社区动脉粥样硬化风险研究;n=1595)、MESA(动脉粥样硬化多民族研究;n=6632)和 PREVEND(预防肾脏和血管终末期疾病;n=5022)。在调整后的 Cox 比例风险模型中分析了 HDL 标志物与 MI 和缺血性卒中的关系。
在总体人群(n=15784)中,HDL-P 与 MI 和缺血性卒中的复合结局呈负相关,经心血管代谢危险因素校正(四分位 4 [Q4]与四分位 1 [Q1]的 HR,0.64 [95%CI,0.52-0.78]),HDL-C 也是如此(Q4 与 Q1 的 HR,0.76 [95%CI,0.61-0.94])。调整 HDL-C 并不能减弱 HDL-P 与动脉粥样硬化性心血管疾病之间的负相关关系,而调整 HDL-P 则减弱了 HDL-C 与所有事件之间的所有关联。HDL-P 与总体人群中的 MI 和缺血性卒中的各个终点均呈负相关,包括女性。HDL-P 与白人参与者的 MI 呈负相关,但与黑人参与者的 MI 无关(白人 Q4 与 Q1 的 HR,0.49 [95%CI,0.35-0.69];黑人,1.22 [95%CI,0.76-1.98];=0.001)。同样,HDL-C 与白人参与者的 MI 呈负相关(Q4 与 Q1 的 HR,0.53 [95%CI,0.36-0.78]),但与黑人参与者的 MI 呈弱正相关(Q4 与 Q1 的 HR,1.75 [95%CI,1.08-2.83];<0.0001)。
与 HDL-C 相比,HDL-P 在总体人群中与 MI 和缺血性卒中始终相关。HDL-C 和 HDL-P 对 MI 的相关性因黑人种族而存在差异,这表明动脉粥样硬化性心血管疾病的风险可能因血管域和种族而异。未来的研究应分别检查个体结局。